Send me a link:

*Text messaging rates may apply.

 Dow Up 0.13% Nasdaq Down 0.10%

Theravance Inc. (THRX)

-NasdaqGS
22.00 0.94(4.10%) Jul 28, 4:00PM EDT
Prev Close:22.94
Open:22.53
Bid:16.14 x 100
Ask:N/A
1y Target Est:28.83
Beta:0.63
Next Earnings Date:N/A
Day's Range:21.82 - 22.67
52wk Range:20.23 - 34.53
Volume:1,463,905
Avg Vol (3m):1,336,500
Market Cap:2.48B
P/E (ttm):N/A
EPS (ttm):-1.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
THRXDown 4.10%2.48B
AZN93.18B
CBST4.64B
PFE192.00B

Key Statistics

Forward P/E (1 yr):169.23
P/S (ttm):721.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.19
Quarterly EPS Est (Jun-14) :-0.44
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback